Position in VRTX
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$2,348,353
-$35,867 QoQ
Shares Held
5,259
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vise Technologies, Inc. holds $12,234,017 across 26 Biotechnology names. VRTX ranks #1 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5,259 | $2,348,353 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,402 | $1,083,241 | |
| 3 | INSM |
INSMED Inc
|
6,314 | $1,032,465 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
9,842 | $670,535 | |
| 5 | RPRX |
Royalty Pharma plc
|
10,651 | $510,928 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,515 | $501,268 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
7,424 | $479,813 | |
| 8 | ARGX |
Argenx SE
|
620 | $452,755 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,348,353 | 5,259 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,384,220 | 5,259 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,653,895 | 4,223 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,904,565 | 4,278 | Shares | Sole | 2025-08-07 | |
| 2024-12-31 | $1,131,184 | 2,809 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $540,888 | 1,163 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||